UK scientists receive funding to develop world’s first ovarian cancer vaccine
HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project.
Drugs
Health
Pharma
Health
Medical
Pharma
J&J’s $6.5B settlement plan amid ongoing talc lawsuits finds favour
HQ Team August 14, 2024: Johnson & Johnson (J&J) is nearing settlement of lawsuits alleging that its talc-based baby powder caused cancer. Over.
Drugs
Health
Pharma
GenX faces a higher risk of 17 cancer types than older generation
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.
Drugs
Health
Medical
Walkable environs cut risk of obesity-related cancers in women
HQ Team October 5, 2023: A new study by Columbia University Mailman School of Public Health and NYU Grossman School of Medicine says.
Drugs
Health
Pharma
US-based Nuvectis Pharma starts human trial on solid tumors
HQ Team September 12, 2023: Nuvectis Pharma, Inc., a US biopharmaceutical firm, has started its experimental trial in humans to treat solid tumors..
Drugs
Medical
Pharma
Blood cancer therapy may help to treat ovarian cancer: Swedish scientists
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.
Drugs
Pharma
FDA approves Immunogen’s drug for advanced ovarian cancer
The Food and Drug Administration approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose.
Drugs
Pharma
Alembic gets USFDA nod for oncology injection Paclitaxel
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.